Syntheses of Acutiphycin and Dehydroacutiphycin
J. Am. Chem. Soc., Vol. 119, No. 45, 1997 10945
For (+)-36a: [R]2D5 +19° (c 0.91, CHCl3); IR (CHCl3) 3470 (w,
br), 2990 (m), 2950 (s), 2920 (s), 1720 (s), 1460 (m), 1105 (s), 1005
(s), 690 (s) cm-1; 1H NMR (500 MHz, CDCl3) δ 7.68-7.65 (m, 4 H),
7.44-7.35 (m, 6 H), 5.38 (apparent t, J ) 7.0 Hz, 1 H), 5.20 (apparent
dd, J ) 11.1, 0.9 Hz, 1 H), 4.70-4.65 (m, 1 H), 4.27 (s, 1 H), 4.10-
4.03 (m, 1 H), 3.90 (dd, J ) 11.9, 2.5 Hz, 1 H), 2.98 (apparent t, J )
8.6 Hz, 1 H), 2.95 (s, 3 H), 2.79 (d, J ) 7.9 Hz, 1 H), 2.67-2.59 (m,
1 H), 2.52 (ABq, JAB ) 13.1 Hz, ∆υAB ) 29.1 Hz, 2 H), 2.42-2.37
(m, 2 H), 2.13-2.07 (m, 1 H), 1.99 (ddd, J ) 11.2, 4.5, 1.5 Hz, 1 H),
1.72 (d, J ) 1.1 Hz, 3 H), 1.72-1.68 (m, 1 H), 1.62 (apparent q, J )
12.1 Hz, 1 H), 1.62 (s, 3 H), 1.47-1.40 (m, 1 H), 1.34 (dd, J ) 12.7,
10.9 Hz, 1 H), 1.31-1.22 (m, 7 H), 1.08 (d, J ) 6.3 Hz, 3 H), 1.08 (s,
3 H), 1.05 (s, 9 H), 0.87 (t, J ) 7.0 Hz, 3 H), 0.72 (s, 3 H); 13C NMR
(125.8 MHz, CDCl3) δ 169.2, 135.9, 135.8, 134.3, 133.6, 130.7, 129.65,
129.63, 127.60, 127.59, 125.4, 100.2, 87.0, 81.5, 76.8, 74.7, 66.1, 49.9,
44.5, 43.1, 42.0, 38.7, 38.4, 34.3, 31.7, 30.9, 27.0, 26.3, 25.0, 22.52,
22.48, 19.9, 19.1, 14.0, 12.3, 11.5; high-resolution mass spectrum (FAB,
NBA matrix) m/z 757.4491 [(M + Na)+; calcd for C44H66O7SiNa
757.4476].
ethyl acetate, 9:1) furnished (+)-37a (6.0 mg, 65% yield) as a colorless
oil: [R]2D5 +25° (c 0.54, CHCl3); IR (CHCl3) 2975 (s), 2940 (s), 2880
(s), 2870 (s), 1720 (s), 1460 (m), 1230 (s), 1215 (s), 1200 (s), 1115
1
(s), 1060 (s), 1040 (s), 1005 (s), 700 (s) cm-1; H NMR (500 MHz,
CD3OD) δ 7.72-7.65 (m, 4 H), 7.45-7.36 (m, 6 H), 5.59 (apparent t,
J ) 6.4 Hz, 1 H), 5.40 (d, J ) 10.8 Hz, 1 H), 4.81 (m, 1 H), 4.18 (s,
1 H), 4.13 (m, 1 H), 3.71 (d, J ) 11.6 Hz, 1 H), 3.06 (d, J ) 8.8 Hz,
1 H), 2.95 (s, 3 H), 2.64-2.57 (m, 1 H), 2.62 (ABq, JAB ) 14.1 Hz,
∆υAB ) 190.3 Hz, 2 H), 2.49-2.43 (m, 1 H), 2.31-2.25 (m, 1 H),
1.96 (ddd, J ) 12.6, 4.6, 1.6 Hz, 1 H), 1.92-1.86 (m, 1 H), 1.82 (dd,
J ) 12.5, 10.9 Hz, 1 H), 1.71-1.63 (m, 1 H), 1.63 (s, 3 H), 1.58 (d,
J ) 0.8 Hz, 3 H), 1.52-1.45 (m, 1 H), 1.41-1.27 (m, 8 H), 1.05 (s,
9 H), 0.96 (t, J ) 7.9 Hz, 9 H), 0.948 (s, 3 H), 0.947 (d, J ) 7.8 Hz,
3 H), 0.89 (t, J ) 6.9 Hz, 3 H), 0.89 (s, 3 H), 0.61 (q, J ) 7.9 Hz, 6
H); 13C NMR (125.8 MHz, CD3OD) δ 171.1, 139.0, 136.92, 136.88,
135.4, 131.7, 131.1, 130.9, 128.73, 128.72, 126.8, 101.0, 83.4, 76.3,
74.9, 68.0, 46.0, 44.3, 43.8, 40.3, 37.9, 35.1, 33.0, 31.9, 27.6, 26.6,
23.6, 22.6, 20.2, 19.9, 14.4, 14.1, 13.8, 7.5, 6.2; high-resolution mass
spectrum (FAB, NBA matrix) m/z 871.5334 [(M + Na)+; calcd for
C50H80O7Si2Na 871.5341].
Macrolides (-)-35b and (+)-36b. Seco acid (+)-3b (25.0 mg, 33.3
µmol) was cyclized via the basic procedure described above for the
preparation of (+)-36a; in this case, the mixed anhydride was added
to the solution of 4-(dimethylamino)pyridine over 6 h. Workup and
flash chromatography as before afforded a mixture of (-)-35b and (+)-
TES Ether (+)-37b. Diol (+)-36b (7.5 mg, 10.2 µmol) was
selectively monosilylated as described above for the preparation of (+)-
37a. Workup as before gave (+)-37b (6.1 mg, 71% yield) as a colorless
oil: [R]2D5 +22° (c 0.41, CHCl3); IR (CHCl3) 3470 (w, br), 2990 (m),
2950 (s), 2920 (s), 2870 (s), 2850 (s), 1715 (s), 1455 (m), 1210 (s),
1
36b (18.4 mg, 69.7% yield; ca. 3.3:1 by H NMR). Treatment of the
1
1105 (s), 1035 (s), 1000 (s), 690 (s) cm-1; H NMR (500 MHz, CD3-
macrolides (15.5 mg) with methanolic citric acid, workup, and flash
chromatography as before furnished the desired macrolide (+)-36b (10.9
mg, 68% yield) and 35b (minor component) as a colorless oil: (-)-
35b: [R]2D5 -13° (c 0.44, CHCl3); IR (CHCl3) 3490 (w, br), 3000 (m),
2955 (s), 2925 (s), 1730 (s), 1675 (m), 1215 (s), 1105 (s), 1005 (s),
695 (s) cm-1; 1H NMR (500 MHz, CDCl3) δ 7.68-7.65 (m, 4 H), 7.44-
7.36 (m, 6 H), 5.45-5.34 (m, 2 H), 5.22 (d, J ) 10.8 Hz, 1 H), 5.17
(apparent d, J ) 10.2 Hz, 1 H), 4.77-4.72 (m, 1 H), 4.61-4.58 (m, 1
H), 4.60 (s, 1 H), 4.15 (s, 1 H), 4.12 (d, J ) 12.3 Hz, 1 H), 3.19
(apparent d, J ) 14.9 Hz, 1 H), 2.97-2.93 (m, 1 H), 2.86 (d, J ) 14.8
Hz, 1 H), 2.80 (d, J ) 8.4 Hz, 1 H), 2.66-2.58 (m, 1 H), 2.37-2.27
(m, 2 H), 2.07 (apparent t, J ) 13.4 Hz, 1 H), 2.01-1.93 (m, 3 H),
1.81-1.77 (m, 1 H), 1.67 (s, 3 H), 1.62 (s, 6 H), 1.26 (s, 2 H), 1.06 (d,
J ) 11.7 Hz, 3 H), 1.06 (s, 12 H), 0.69 (s, 3 H); 13C NMR (125.8
MHz, CDCl3) δ 170.0, 149.3, 135.78, 135.74, 135.6, 134.2, 134.1,
134.0, 130.6, 130.1, 129.70, 129.67, 127.6, 125.5, 125.3, 104.4, 86.9,
82.8, 81.7, 73.8, 65.8, 42.1, 40.5, 38.7, 35.5, 35.2, 32.2, 28.2, 27.0,
26.8, 22.7, 19.7, 19.1, 17.9, 12.7, 10.6; high-resolution mass spectrum
(FAB, NBA matrix) m/z 723.4068 [(M + Na)+; calcd for C43H60O6-
SiNa 723.4057].
For (+)-36b: [R]2D5 +19° (c 0.3, CHCl3); IR (CHCl3) 3500 (w, br),
3000 (m), 2950 (m), 2920 (s), 1715 (m), 1455 (m), 1195 (s), 1105 (s),
1005 (s), 695 (s), 655 (m) cm-1; 1H NMR (500 MHz, CDCl3) δ 7.67-
7.65 (m, 4 H), 7.44-7.36 (m, 6 H), 5.45-5.34 (m, 3 H), 5.19 (d, J )
11.1 Hz, 1 H), 4.72-4.67 (m, 1 H), 4.27 (s, 1 H), 4.09-4.03 (m, 1 H),
3.90 (dd, J ) 11.7, 2.4 Hz, 1 H), 2.98 (apparent t, J ) 8.4 Hz, 1 H),
2.95 (s, 3 H), 2.75 (d, J ) 7.9 Hz, 1 H), 2.66-2.60 (m, 1 H), 2.51
(ABq, JAB ) 13.1 Hz, ∆υAB ) 26.1 Hz, 2 H), 2.40 (ddd, J ) 15.1, 8.1,
3.2 Hz, 1 H), 2.36 (s, 1 H), 2.13-2.07 (m, 1 H), 2.01-1.94 (m, 3 H),
1.72 (d, J ) 0.9 Hz, 3 H), 1.68-1.65 (m, 1 H), 1.62 (d, J ) 6.0 Hz,
3 H), 1.62 (s, 3 H), 1.52-1.45 (m, 1 H), 1.34 (dd, J ) 12.7, 10.9 Hz,
1 H), 1.30-1.20 (m, 2 H), 1.26 (s, 3 H), 1.08 (d, J ) 5.0 Hz, 3 H),
1.05 (s, 9 H), 0.71 (s, 3 H); 13C NMR (125.8 MHz, CDCl3) δ 169.1,
136.0, 135.8, 134.3, 133.5, 130.8, 130.2, 130.0, 129.7, 129.6, 127.6,
125.5, 125.2, 100.2, 87.0, 81.5, 76.8, 74.2, 66.1, 49.9, 44.5, 43.1, 42.0,
38.7, 38.5, 34.0, 30.8, 28.5, 27.0, 26.3, 22.5, 19.9, 19.1, 17.9, 12.3,
11.4; high-resolution mass spectrum (FAB, NBA matrix) m/z 755.4336
[(M + Na)+; calcd for C44H64O7SiNa 755.4319].
OD) δ 7.68-7.65 (m, 4 H), 7.45-7.36 (m, 6 H), 5.58 (apparent t, J )
6.6 Hz, 1 H), 5.49-5.39 (m, 2 H), 5.39 (d, J ) 10.8 Hz, 1 H), 4.84-
4.77 (m, 1 H), 4.19 (s, 1 H), 4.13 (m, 1 H), 3.72 (d, J ) 10.8 Hz, 1 H),
3.06 (d, J ) 8.7 Hz, 1 H), 2.95 (s, 3 H), 2.62 (ABq, JAB ) 14.1 Hz,
∆υAB ) 185.0 Hz, 2 H), 2.60 (ddd, J ) 15.3, 8.7, 6.6 Hz, 1 H), 2.50-
2.43 (m, 2 H), 2.31-2.24 (m, 1 H), 2.06-1.99 (m, 1 H), 1.96 (ddd, J
) 11.2, 4.9, 1.8 Hz, 1 H), 1.92-1.70 (m, 3 H), 1.63 (s, 3 H), 1.62 (d,
J ) 4.7 Hz, 3 H), 1.59 (d, J ) 0.8 Hz, 3 H), 1.57-1.50 (m, 1 H), 1.39
(apparent q, J ) 11.9 Hz, 1 H), 1.05 (s, 9 H), 0.954 (t, J ) 8.0 Hz, 9
H), 0.949 (s, 3 H), 0.948 (d, J ) 5.6 Hz, 3 H), 0.89 (s, 3 H), 0.60 (q,
J ) 7.9 Hz, 6 H); 13C NMR (125.8 MHz, CD3OD) δ 171.0, 139.0,
136.92, 136.89, 135.41, 135.35, 131.7, 131.4, 131.1, 130.9, 128.8, 128.7,
126.7, 126.5, 101.0, 83.4, 75.9, 75.0, 68.9, 68.0, 46.0, 44.3, 43.8, 40.3,
38.0, 34.9, 31.8, 29.9, 27.6, 26.5, 22.6, 20.2, 19.9, 18.1, 14.1, 13.7,
7.5, 6.2; high-resolution mass spectrum (FAB, 1-thioglycerol matrix)
m/z 869.5170 [(M + Na)+; calcd for C50H78O7Si2Na 869.5184].
Ketone (+)-38a. The Dess-Martin periodinane (0.15 g, 0.34 mmol)
was dissolved in CH2Cl2 (10.7 mL), and pyridine (0.14 mL, 1.71 mmol)
was added, producing a clear stock solution which was used within 5
min. At room temperature alcohol (+)-37a (8.4 mg, 9.9 µmol) was
treated with a portion of the periodinane solution (5.01 mL). After an
additional 20 min, the reaction mixture was diluted with ether (5 mL),
and the reaction was quenched with saturated aqueous NaHCO3 and
NaHSO3
(1:1, 5 mL). The resultant mixture was stirred for 5 min,
diluted with ether (20 mL), washed with saturated aqueous NaHCO3
(2 × 10 mL) and brine (15 mL), dried over MgSO4, filtered, and
concentrated. Flash chromatography (hexanes/ethyl acetate, 9:1)
furnished (+)-38a (8.0 mg, 96% yield) as a colorless oil: [R]2D5 +112°
(c 0.73, CHCl3); IR (CHCl3) 1705 (s), 1455 (m), 1205 (s), 1110 (s),
1070 (s), 1040 (s), 695 (s) cm-1; 1H NMR (500 MHz, CDCl3) δ 7.68-
7.63 (m, 4 H), 7.44-7.35 (m, 6 H), 5.40 (d, J ) 10.3 Hz, 1 H), 5.25
(apparent t, J ) 6.8 Hz, 1 H), 4.90-4.86 (m, 1 H), 4.18 (s, 1 H), 4.14-
4.08 (m, 1 H), 3.99-3.93 (m, 1 H), 3.67 (d, J ) 11.8 Hz, 1 H), 2.94
(s, 3 H), 2.62 (ABq, JAB ) 14.3 Hz, ∆υAB ) 244.0 Hz, 2 H), 2.27-
2.25 (m, 2 H), 1.97 (ddd, J ) 12.8, 4.8, 1.6 Hz, 1 H), 1.96 (ddt, J )
12.3, 4.4, 2.2 Hz, 1 H), 1.78 (dd, J ) 12.8, 10.7 Hz, 1 H), 1.68-1.57
(m, 1 H), 1.59 (s, 3 H), 1.56 (d, J ) 1.0 Hz, 3 H), 1.41-1.35 (m, 1 H),
1.31-1.23 (m, 6 H), 1.29 (s, 3 H), 1.18 (apparent q, J ) 12.0 Hz, 1
H), 1.04 (s, 9 H), 1.00 (d, J ) 6.7 Hz, 3 H), 0.99 (s, 3 H), 0.96 (t, J
) 8.0 Hz, 9 H), 0.87 (t, J ) 7.0 Hz, 3 H), 0.60 (q, J ) 7.9 Hz, 6 H);
13C NMR (125.8 MHz, CDCl3) δ 214.5, 169.3, 137.6, 135.8, 135.7,
134.5, 134.2, 133.7, 129.7, 127.58, 127.57, 125.2, 123.2, 99.3, 80.1,
74.4, 72.4, 66.4, 56.2, 48.1, 43.5, 42.0, 40.4, 38.7, 33.1, 31.8, 30.7,
26.9, 25.5, 24.2, 22.6, 19.3, 19.0, 18.6, 14.0, 13.5, 13.1, 7.0, 4.9; high-
resolution mass spectrum (FAB, NBA matrix) m/z 869.5168 [(M +
Na)+; calcd for C50H78O7Si2Na 869.5184].
TES Ether (+)-37a. A stock solution was prepared at 0 °C by
dissolving 2,6-lutidine (57 µL, 0.49 mmol) and triethylsilyl trifluo-
romethanesulfonate (50 µL, 0.22 mmol) in CH2Cl2 (14.7 mL), and a
portion (2.2 mL) was then added to a flask containing diol (+)-36a
(8.0 mg, 10.9 µmol) at -78 °C. The reaction mixture was stirred for
an additional 20 min, and the reaction was quenched with MeOH (15
µL) and diluted with Et2O (10 mL). The organic phase was washed
with 0.1 M aqueous NaHSO4 (4 mL) and brine (4 mL), dried over
MgSO4, filtered, and concentrated. Flash chromatography (hexanes/